Error: Could not add to watchlist. X

Rydex Series - Biotechnology Fund

+ Watchlist
RYOAX:US
NASDAQ GM
94.20
USD
0.09
0.10%
As of 20:00:00 ET on 07/31/2015.
Fund Type
Open-End Fund
52Wk Range
62.58 - 98.88
1 Yr Return
50.06%
YTD Return
25.53%
Open
94.20
Day Range
94.20 - 94.20
Previous Close
94.11
52Wk Range
62.58 - 98.88
1 Yr Return
50.06%
YTD Return
25.53%
Fund Type
-
Objective
-
Asset Class Focus
-
Geographic Focus
-
NAV (on 07/30/2015)
94.2
Total Assets (m USD) (on 07/30/2015)
869.509
Inception Date
04/01/1998
Last Dividend (on 11/18/2014)
2.5745
Dividend Indicated Gross Yield
-
Fund Managers
MICHAEL PAUL BYRUM / RYAN A HARDER
Front Load Fee
0.00%
Back Load Fee
0.00%
Redemption Fee
-
12b-1 Fee
0.25%
Current Mgmt Fee
0.85%
Expense Ratio
1.83%
Top Fund Holdings
Name Position Value % of Fund
Gilead Sciences Inc 528.24 k 61.85 m 7.42
Amgen Inc 315.64 k 48.46 m 5.81
Biogen Inc 110.80 k 44.76 m 5.37
Celgene Corp 378.19 k 43.77 m 5.25
Regeneron Pharmaceuticals Inc 66.81 k 34.08 m 4.09
Alexion Pharmaceuticals Inc 146.03 k 26.40 m 3.17
Vertex Pharmaceuticals Inc 199.97 k 24.69 m 2.96
Illumina Inc 112.82 k 24.64 m 2.95
BioMarin Pharmaceutical Inc 161.94 k 22.15 m 2.66
Incyte Corp 187.20 k 19.51 m 2.34
Profile
Rydex Series - Biotechnology Fund is an open-end fund incorporated in the USA. The Fund's objective is capital appreciation. The Fund invests its assets in companies that are involved in the biotechnology industry, including companies involved in research and development, genetic or other biological engineering, and in the design, manufacture, or sale of related biotechnology products.
ADDRESS
Rydex Funds
9601 Blackwell Road
Suite 500
Rockville, MD 20850
USA
PHONE
1-301-296-5100